One dose of UNISTRAIN® PRRS in gestating sows clinically protects against heterologous PRRS infection

Home Knowledge One dose of UNISTRAIN® PRRS in gestating sows clinically protects against heterologous PRRS infection

One dose of UNISTRAIN® PRRS in gestating sows clinically protects against heterologous PRRS infection

After evidences for vaccine-induced protective immunity against non-homologous challenge (1, 2), in this study the heterologous efficacy of UNISTRAIN® PRRS was assessed but in naïve gestating sow model. Reproductive performance was the main parameter to claim the efficacy.

About this article

Appeared in

ESPHM Congress, 2013

Authors

Fenech, M.; Pla, H.; Madeo, X.; Roca, M.; Ros, M.; Sitjà, M.

Summary

It was clearly confirmed that vaccination with UNISTRAIN® PRRS during the second part of gestation was safe and able to reduce reproductive consequences of a heterologous PRRS infection at third trimester (were sows are more sensitive to the virus).

Related products

Share this on